Other members of the partnership include the African Centres for Disease Control and Prevention (CDC ), the Clinton Health Access Initiative (CHACCI ), and Unitaid Executive Director of the Global Fund Peter Sands.
Covid tests that give results in 15 to 30 minutes will be spread throughout the world in a move that could save thousands of lives and slow down the pandemic worldwide.
The Access to Covid Tools initiative (ACT Accelerator) was launched by the WHO, the European Commission, the Gates Foundation and the French government in March 2005. Well-to-do nations that have registered, including the UK, will also be able to order the tests.
She said : ‘We see rapid rises of the pressure of supply. We need this volume guarantee! We needed to secure volumes for Low and Middle Income Countries before all the other countries placed their orders and the poor populations lost out again.
“For us, the message is about unprecedented collaboration. We are really able to show what can be accomplished when the world and leading global health partners meet with a shared priority.
Other members of the partnership are the Africa Centres for Disease Control and Prevention (CDC ), the Clinton Health Access Initiative (CHACCI), the Global Fund and Unitaid
Executive Director of the Global Fund Peter Sands said : This is the ACT Accelerator in action It is proof that we can develop and deploy a vital new tool at a global scale to help contain and fight the pandemic.
It is not just a new test – it is the money and the deployment plan to get it quickly where it needs to be at. This is the power of global collaboration.
Other rapid antigen test is available online, but they do not meet WHO specification and may be unreliable. In March, Spain had to return batches of tests bought from Chinese unlicensed companies, saying they only identified the virus 90% of the time.
However, these companies claim that their tests are about 97% accurate, while Find estimates that the accuracy is realistically between 80% and 90% – this means that most infections would be detected.
Mass-testing is urgently needed in most low- and middle-income countries. While North America tests 395 people for 100,000 population daily and Europe tests 243, Africa tests fewer than 16.
The ACT accelerator initiative also plans to buy and distribute covid drugs around the world and share its global vaccine portfolio when they find one that works.